SAMPAOLESI, MAURILIO
 Distribuzione geografica
Continente #
NA - Nord America 4.607
EU - Europa 3.191
AS - Asia 2.353
OC - Oceania 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 5
Totale 10.188
Nazione #
US - Stati Uniti d'America 4.586
CN - Cina 2.131
IE - Irlanda 1.003
UA - Ucraina 608
FI - Finlandia 439
DE - Germania 339
IT - Italia 232
SE - Svezia 196
SG - Singapore 180
GB - Regno Unito 172
BE - Belgio 92
FR - Francia 71
IN - India 23
CA - Canada 21
AU - Australia 11
NL - Olanda 11
CZ - Repubblica Ceca 9
IR - Iran 9
EU - Europa 8
RU - Federazione Russa 6
BR - Brasile 5
MU - Mauritius 4
CH - Svizzera 3
EC - Ecuador 3
GR - Grecia 3
KR - Corea 3
AR - Argentina 2
BD - Bangladesh 2
LV - Lettonia 2
RO - Romania 2
VN - Vietnam 2
AT - Austria 1
CL - Cile 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
Totale 10.188
Città #
Dublin 1.003
Chandler 938
Jacksonville 786
Nanjing 640
Ashburn 346
Boardman 339
Nanchang 270
Princeton 215
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 178
Ann Arbor 157
Jiaxing 157
Changsha 153
Beijing 123
Helsinki 116
Singapore 106
Hangzhou 103
Tianjin 100
Milan 76
Woodbridge 62
Shanghai 54
Pavia 53
Verona 51
Brussels 39
Herent 33
Norwalk 31
Los Angeles 29
Fairfield 26
Kunming 23
Seattle 22
Leuven 20
Pune 20
Washington 20
Des Moines 19
Guangzhou 16
Auburn Hills 15
Toronto 15
Falls Church 14
Houston 13
Jinan 13
New York 12
Redwood City 11
Zhengzhou 11
Dearborn 10
Munich 9
Ningbo 9
Brno 8
Taizhou 8
Lanzhou 7
Orange 7
San Francisco 6
Changchun 4
Dallas 4
Ardabil 3
Borås 3
Buffalo 3
Chicago 3
Fuzhou 3
Gunzenhausen 3
Gwanak-gu 3
Hamburg 3
Las Vegas 3
Lausanne 3
Quito 3
Redmond 3
Shijiazhuang 3
Brisbane 2
Dong Ket 2
Ferrara di Monte Baldo 2
Frankfurt am Main 2
Helsingborg 2
Miami 2
Newark 2
Rozzano 2
Santa Clara 2
Sydney 2
Tappahannock 2
Varese 2
Walnut 2
Zanjan 2
Aberystwyth 1
Amsterdam 1
Berlin 1
Bitonto 1
Bologna 1
Bondeno 1
Buenos Aires 1
Canberra 1
Cheyenne 1
Ciampino 1
Collegno 1
Colombo 1
Cornaredo 1
Deventer 1
Doha 1
Doncaster 1
Duncan 1
Totale 7.390
Nome #
Evaluation of energy expenditure in athletes practising horseback riding 107
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 103
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 99
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 99
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 98
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 97
Electromagnetic fields influence the gene expression of SAOS-2 cell line 96
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 95
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 94
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 93
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 88
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 83
Cell therapy strategies and improvements for muscular dystrophy. 81
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 76
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 75
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 74
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 72
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 71
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 70
Adult Stem Cells and Skeletal Muscle Regeneration 70
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 69
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 68
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 68
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 67
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 67
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 67
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 67
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 66
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 66
Hamster cardiomyocytes: a model of myocardial regeneration? 66
Gene signature of muscle hypertrophy 66
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 66
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 65
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 65
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 65
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 65
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 64
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 64
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 64
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 64
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 64
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 63
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 63
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 62
New therapies for muscular dystrophy: cautious optimism. 62
Brief Communication Arising 62
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 62
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 61
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 61
Skeletal muscle engineering: scaffolds and recombinant proteins 61
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 60
Stem Cell homing and regulation: new insights from muscular dystrophy 60
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 60
About Mesoangioblasts 59
Stem cell-niche and lysosomal cathepsins 59
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 59
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 58
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability 58
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 58
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 58
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 58
Alteration of cardiac progenitor cell potency in GRMD dogs 58
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 58
Bedside to bench: a look at experimental research with a clinical trial checklist 58
Muscle hypertrophy and vascularization induction using recombinant proteins 58
Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. 58
Mouse, dog and human mesoangioblasts 57
Magic F1, a dimerized c-met binding domain, induces muscle hypertrophy by protecting from apoptosis myogenic progenitors 57
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 57
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 57
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 56
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 56
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 56
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 56
Caffeine-induced Ca2+ signaling as an index of cardiac differentiation 55
HGF-DERIVED RECOMBINANT PROTEIN MAGIC F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 55
Welcome to Cardiovascular Research in 2015 55
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells 55
Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. 54
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 54
Le cellule staminaliTra scienza, etica e usi terapeutici 54
Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles. 54
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 54
The effects of micro-grafts in the treatment of androgenetic alopecia 54
Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. 53
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 52
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. 52
Myogenic competences of fibroblasts in vitro and in vivo 52
Recombinant proteins and PCL biomaterial to burst myogenesis in vitro 52
Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. 52
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 52
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. 51
Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells 51
Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation 51
Terapia cellulare mesenchimale nella distrofia muscolare 51
In vitro and in vivo tissue engineering approaches in regenerative medicine 51
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 51
Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. 51
Stretch-induced cell damage in sarcoglycan-deficient myotubes. 50
Stem Cell for the Treatment of Muscle Distrophy: More Than a Wishful Thinking? 50
Totale 6.436
Categoria #
all - tutte 43.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020567 0 0 0 0 11 124 17 125 20 184 83 3
2020/20211.178 133 106 31 116 12 145 14 203 60 176 142 40
2021/2022860 19 6 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/2025512 38 242 116 78 38 0 0 0 0 0 0 0
Totale 10.432